CLOV CLOVER HEALTH INV CORP

Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023

Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023

FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will present at Citi's 2023 Healthcare Conference on Wednesday, March 1, 2023, at 8:45 a.m. Eastern Time.

A live webcast of the presentation will be accessible from Clover Health's investor relations website at . An archived replay of the presentation will be available from the same website for 12 months following the live presentation.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:

Andrew Still-Baxter

Emma Baron

Investor Relations Contact:

Ryan Schmidt



EN
22/02/2023

Underlying

CLOVCLOVER HEALTH INV CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare C...

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a p...

December 16, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare C...

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a physician en...

November 17, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Reports Third Quarter 2025 Results

Clover Health Reports Third Quarter 2025 Results Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member baseHigh coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning member cohorts position Clover for improved positive FY26 Financial Results Financial Results: Third quarter 202...

November 4, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Announces Chelsea Clinton to Step Down from Board Follow...

Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025. During her over eight years of dedicated service, Ms. Clinton played a pivotal role in guiding Clover’s evolution from a privately held company serving 30,000 members to a...

October 31, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Primary Care Physician Use of Counterpart Assistant (CA) Technology As...

Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a w...

October 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch